Evidence map›Paper›PMID 35006540›Full record

ArticleBrain imaging and behavior2022

Brain 5-HT

Kazuho Kojima, Shigeki Hirano, Yasuyuki Kimura, Chie Seki, Yoko Ikoma, Keisuke Takahata, Takehito Ito, Keita Yokokawa, Hiroki Hashimoto, Kazunori Kawamura and 6 more

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Brain imaging and behavior, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.1field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 1 country.

Kazuho KojimaDepartment of Neurology, Graduate School of Medicine, Chiba University, Chiba, 260-8670, Japan.
Shigeki HiranoDepartment of Neurology, Graduate School of Medicine, Chiba University, Chiba, 260-8670, Japan.
Yasuyuki KimuraDepartment of Clinical and Experimental Neuroimaging, Center for Development of Advanced Medicine for Dementia, National Center for Geriatrics and Gerontology, Obu, 474-8511, Japan.
Chie SekiDepartment of Functional Brain Imaging, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology, Chiba, 263-8555, Japan.
Yoko IkomaDepartment of Molecular Imaging and Theranostics, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology, Chiba, 263-8555, Japan.
Keisuke TakahataDepartment of Functional Brain Imaging, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology, Chiba, 263-8555, Japan.
Takehito ItoDepartment of Functional Brain Imaging, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology, Chiba, 263-8555, Japan.
Keita YokokawaDepartment of Functional Brain Imaging, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology, Chiba, 263-8555, Japan.
Hiroki HashimotoDepartment of Advanced Nuclear Medicine Sciences, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology, Chiba, 263-8555, Japan.
Kazunori KawamuraDepartment of Advanced Nuclear Medicine Sciences, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology, Chiba, 263-8555, Japan.
Ming-Rong ZhangDepartment of Advanced Nuclear Medicine Sciences, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology, Chiba, 263-8555, Japan.
Hiroshi ItoDepartment of Radiology and Nuclear Medicine, Fukushima Medical University, Fukushima, 960-1295, Japan.
Makoto HiguchiDepartment of Functional Brain Imaging, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology, Chiba, 263-8555, Japan.
Satoshi KuwabaraDepartment of Neurology, Graduate School of Medicine, Chiba University, Chiba, 260-8670, Japan.
Tetsuya SuharaInstitute for Quantum Life Science, National Institutes for Quantum Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba, Chiba, 263-8555, Japan.
Makiko YamadaDepartment of Functional Brain Imaging, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology, Chiba, 263-8555, Japan. yamada.makiko@qst.go.jp.ORCID http://orcid.org/0000-0002-2897-3045
National Institutes for Quantum Science and Technology · JPChiba University · JPFukushima Medical University · JPNational Center for Geriatrics and Gerontology · JP

Funding

AMED dm0107094AMED dm0207007Japan Society for the Promotion of Science 17H02173Japan Society for the Promotion of Science 20H05711MEXT Quantum Leap Flagship Program JPMXS0120330644
6 · The paper itself

Abstract

The tendency to avoid punishment, called behavioral inhibition system, is an essential aspect of motivational behavior. Behavioral inhibition system is related to negative affect, such as anxiety, depression and pain, but its neural basis has not yet been clarified. To clarify the association between individual variations in behavioral inhibition system and brain 5-HT

Indexed as

Magnetic Resonance ImagingReceptor, Serotonin, 5-HT2ABrainBrain MappingHumansInhibition, PsychologicalMaleNeural Networks, ComputerNeural PathwaysReceptor, Serotonin, 5-HT2ABehavioral inhibition systemCingulate cortexPositron emission tomographyResting state functional magnetic resonance imageSerotonin system

Identifiers

PMID35006540
PMCPMC9107428
OpenAlexW4206724030

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.